Skip to main content
UW Medicine | NewsroomNews and information for journalists
UW Medicine | NewsroomNews and information for journalists
Donanemab | Patient undergoes infusion

Donanemab | Patient undergoes infusion

Media Contact: Susan Gregg - 206-390-3226, sghanson@uw.edu

picture of patient Bob Pringle receiving donanemab IV at Harborview Medical Center in Seattle
UW Medicine Bob Pringle receives a donanemab IV at Harborview Medical Center in Seattle.

UW Medicine patient Bob Pringle, 76, of Woodinville, Washington, receives intravenous donanemab to treat Alzheimer's disease in April 2025 at Harborview Medical Center in Seattle.  See associated news release.